Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal ...
Many people think eye exams are only useful for checking vision. However, scientists have discovered that our eyes can reveal much more about our health than just how well we see. In particular, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results